Literature DB >> 22964291

Evaluation of rapid tests for human immunodeficiency virus as a tool to detect recent seroconversion.

Samira Barboza Girardi1, Angela Maria Egydio de Carvalho Barreto, Claudia Cortese Barreto, Anna Barbara Proietti, Silvia Maia Farias de Carvalho, Paula Loureiro, Ester Cerdeira Sabino.   

Abstract

The identification of recent HIV infection is important for epidemiological studies and to monitor the epidemic. The objective of this study was to evaluate two rapid tests that are easily available to the Brazilian scientific community for using as markers of recent HIV infection. The Rapid Test - HIV-1/2 Bio-Manguinhos (Bio-Manguinhos/Fiocruz, Brazil) and the Rapid Check HIV 1&2 (NDI-UFES, Center for Infectious Diseases, Universidade Federal do Espírito Santo) were tested, using 489 samples with HIV positive serology, from blood donors, previously classified as recent or long-term infection by serological testing algorithm for recent HIV seroconversion (STARHS) or LS-HIV Vitros assay methods. The samples were diluted prior to testing (1:50 and 1:100 for the Rapid Test - HIV-1/2 Bio-Manguinhos, and 1:500 and 1:600 for the Rapid Check HIV 1&2). Negative samples were considered recent infection, whereas those showing any color intensity were associated with long-term infection. The best dilutions were 1:100 for HIV-1/2 Bio-Manguinhos test (Kappa = 0.840; overall agreement = 0.93), and 1:500 for the Rapid Check HIV 1&2 (Kappa = 0.867; overall agreement = 0.94). The results suggest that both rapid tests can be used to detect recent seroconversion.
Copyright © 2012 Elsevier Editora Ltda. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964291     DOI: 10.1016/j.bjid.2012.08.013

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  2 in total

1.  Dilution testing using rapid diagnostic tests in a HIV diagnostic algorithm: a novel alternative for confirmation testing in resource limited settings.

Authors:  Leslie Shanks; M Ruby Siddiqui; Almaz Abebe; Erwan Piriou; Neil Pearce; Cono Ariti; Johnson Masiga; Libsework Muluneh; Joseph Wazome; Koert Ritmeijer; Derryck Klarkowski
Journal:  Virol J       Date:  2015-05-14       Impact factor: 4.099

2.  Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 Incidence.

Authors:  Zhiyun Gao; Hao Yan; Xia Feng; Lijin Wu; Maofeng Qiu; Wenge Xing; Guiyun Zhang; Zhi Zhang; Yan Jiang
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.